ImmuCell (NASDAQ:ICCC) Stock Passes Below 50-Day Moving Average of $6.48

ImmuCell Co. (NASDAQ:ICCC)’s share price passed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $6.48 and traded as low as $6.44. ImmuCell shares last traded at $6.44, with a volume of 344 shares.

The company has a debt-to-equity ratio of 0.27, a quick ratio of 6.25 and a current ratio of 7.26. The business has a 50 day simple moving average of $6.49.

ImmuCell (NASDAQ:ICCC) last released its quarterly earnings results on Monday, May 13th. The biotechnology company reported $0.03 earnings per share (EPS) for the quarter. ImmuCell had a negative net margin of 15.62% and a negative return on equity of 5.71%. The firm had revenue of $4.41 million for the quarter.

A hedge fund recently raised its stake in ImmuCell stock. Ingalls & Snyder LLC grew its stake in shares of ImmuCell Co. (NASDAQ:ICCC) by 5.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 96,243 shares of the biotechnology company’s stock after acquiring an additional 4,732 shares during the period. Ingalls & Snyder LLC owned about 1.33% of ImmuCell worth $626,000 at the end of the most recent quarter. 22.62% of the stock is owned by hedge funds and other institutional investors.

About ImmuCell (NASDAQ:ICCC)

ImmuCell Corporation, an animal health company, develops, acquires, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. The company offers First Defense, an orally delivered scours preventive product for calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E.

Featured Story: Equal Weight Rating

Receive News & Ratings for ImmuCell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuCell and related companies with's FREE daily email newsletter.